Updated on 15 June 2026
Strategic partners for medicines workflow pilot-readiness
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
About
I’m open to strategic partnerships that help PHARMORIS move from controlled demo evidence toward safer, clearer and more credible pilot-readiness.
Partnership areas of interest include:
• NHS innovation and medicines optimisation pilots
• regulatory science and standards input
• clinical-safety and IG readiness
• AI assurance and human-review design
• evidence-generation and evaluation frameworks
• accessibility and usability evidence
• procurement and commercialisation pathways
• medtech and healthtech scale-up learning
• investor and strategic partner readiness
The ideal partner is practical, evidence-led and honest about risk. I’m not looking for vague innovation theatre. I’m looking for people who can help turn a serious medicines workflow product into something healthcare organisations can evaluate responsibly.
Looking for
- Research
- Business
- Joint development
- Testing of technology
- Other
Organisation
Similar opportunities
Project cooperation
PHARMORIS pilot-readiness cooperation: evidence, standards and NHS adoption
- Market Access
- Strategic Partnership
- Dissemination project results
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Request
Seeking input on NHS pilot-readiness evidence
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom
Expertise
Evidence-led healthtech, medicines workflow and pilot-readiness
Varun Cruz
Founder, CEO at NEUVIOR® - UK Pharma Infrastructure
London, United Kingdom